Why men may not get genetic testing for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at why some men with metastatic prostate cancer do or don't get a genetic test called NGS. It aims to find barriers to testing, so doctors can better help patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man with metastatic prostate cancer (cancer that has spread to other parts of the body).
- You are a new patient at Johns Hopkins Medical Oncology between January 1, 2025 and December 31, 2026.
- You have not had next-generation sequencing (NGS) genetic testing for your cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study analyzes tumor tissue and blood samples from men with advanced prostate cancer to understand genetic changes that may affect treatment choices. Results may help doctors personalize your treatment plan.
This trial offers support from a trained peer to help African American men understand and go through genetic testing for prostate cancer. It may help you feel less overwhelmed and better prepared during the testing and decision-making process.
This study helps prostate cancer survivors find out if they have inherited genetic changes that increase cancer risk in their family. You'll complete genetic testing and counseling online to learn about your personal and family cancer risk.
This study tests a program that trains men (especially African American men) to help others understand prostate cancer genetic counseling and testing. It may improve access to this information by using peer support and patient navigation.
This study tests whether educational support helps Black men with high-risk prostate cancer complete genetic testing. It may make it easier to get genetic results that can guide care for you and your family.
This study tests a new tool to help Black or African American men with prostate cancer understand genetic testing options. The goal is to improve counseling and decision-making about tumor genetic testing.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.